156 related articles for article (PubMed ID: 9847050)
1. Management of chronic psychotic ambulatory outpatients.
Petty RG
J Clin Psychiatry; 1998; 59 Suppl 19():30-5. PubMed ID: 9847050
[TBL] [Abstract][Full Text] [Related]
2. Using antipsychotic agents in older patients.
Alexopoulos GS; Streim J; Carpenter D; Docherty JP;
J Clin Psychiatry; 2004; 65 Suppl 2():5-99; discussion 100-102; quiz 103-4. PubMed ID: 14994733
[TBL] [Abstract][Full Text] [Related]
3. The expert consensus guideline series. Optimizing pharmacologic treatment of psychotic disorders. Introduction: methods, commentary, and summary.
Kane JM; Leucht S; Carpenter D; Docherty JP;
J Clin Psychiatry; 2003; 64 Suppl 12():5-19. PubMed ID: 14640142
[TBL] [Abstract][Full Text] [Related]
4. [Prescribing patterns of antipsychotics in 13 French psychiatric hospitals].
Bret P; Bret MC; Queuille E
Encephale; 2009 Apr; 35(2):129-38. PubMed ID: 19393381
[TBL] [Abstract][Full Text] [Related]
5. Formulary decisions and health economics.
Glazer WM
J Clin Psychiatry; 1998; 59 Suppl 19():23-9. PubMed ID: 9847049
[TBL] [Abstract][Full Text] [Related]
6. Optimisation of long-term treatment in schizophrenia: treating the true spectrum of symptoms.
Kasper S
Eur Neuropsychopharmacol; 2006 Sep; 16 Suppl 3():S135-41. PubMed ID: 16872809
[TBL] [Abstract][Full Text] [Related]
7. Long-term considerations after switching antipsychotics.
Weiden PJ; Aquila R; Emanuel M; Zygmunt A
J Clin Psychiatry; 1998; 59 Suppl 19():36-49. PubMed ID: 9847051
[TBL] [Abstract][Full Text] [Related]
8. Partial response to antipsychotic treatment: the patient with enduring symptoms.
Emsley RA
J Clin Psychiatry; 1999; 60 Suppl 23():10-3. PubMed ID: 10625194
[TBL] [Abstract][Full Text] [Related]
9. Annual health outcomes and treatment costs for schizophrenia populations.
Mauskopf JA; David K; Grainger DL; Gibson PJ
J Clin Psychiatry; 1999; 60 Suppl 19():14-9; discussion 20-2. PubMed ID: 10507276
[TBL] [Abstract][Full Text] [Related]
10. An overview of side effects caused by typical antipsychotics.
Arana GW
J Clin Psychiatry; 2000; 61 Suppl 8():5-11; discussion 12-3. PubMed ID: 10811237
[TBL] [Abstract][Full Text] [Related]
11. Review of the evidence for the long-term efficacy of atypical antipsychotic agents in the treatment of patients with schizophrenia and related psychoses.
Turner MS; Stewart DW
J Psychopharmacol; 2006 Nov; 20(6 Suppl):20-37. PubMed ID: 17046985
[TBL] [Abstract][Full Text] [Related]
12. Combination of "atypical" antipsychotic medication in the management of treatment-resistant schizophrenia and schizoaffective disorder.
Lerner V; Libov I; Kotler M; Strous RD
Prog Neuropsychopharmacol Biol Psychiatry; 2004 Jan; 28(1):89-98. PubMed ID: 14687862
[TBL] [Abstract][Full Text] [Related]
13. Effectiveness and cost of atypical versus typical antipsychotic treatment for schizophrenia in routine care.
Stargardt T; Weinbrenner S; Busse R; Juckel G; Gericke CA
J Ment Health Policy Econ; 2008 Jun; 11(2):89-97. PubMed ID: 18509216
[TBL] [Abstract][Full Text] [Related]
14. [Drug treatment of functional psychotic disorders].
Bridler R; Umbricht D; Hell D
Praxis (Bern 1994); 2001 May; 90(22):981-6. PubMed ID: 11450186
[TBL] [Abstract][Full Text] [Related]
15. The influence of the CYP2D6 polymorphism on psychopathological and extrapyramidal symptoms in the patients on long-term antipsychotic treatment.
Plesnicar BK; Zalar B; Breskvar K; Dolzan V
J Psychopharmacol; 2006 Nov; 20(6):829-33. PubMed ID: 16478753
[TBL] [Abstract][Full Text] [Related]
16. [25 years antipsychotics: back to the future?].
Denys D; de Haan L
Tijdschr Psychiatr; 2008; 50 Spec no.():105-9. PubMed ID: 19067308
[TBL] [Abstract][Full Text] [Related]
17. Antipsychotics and the quality of life of schizophrenic patients.
Loga-Zec S; Loga S
Psychiatr Danub; 2010 Dec; 22(4):495-7. PubMed ID: 21169888
[TBL] [Abstract][Full Text] [Related]
18. New antipsychotic agents: emerging clinical profiles.
Buckley PF
J Clin Psychiatry; 1999; 60 Suppl 1():12-7; discussion 28-30. PubMed ID: 10037165
[TBL] [Abstract][Full Text] [Related]
19. The efficacy, safety, and tolerability of antipsychotics in the elderly.
Maixner SM; Mellow AM; Tandon R
J Clin Psychiatry; 1999; 60 Suppl 8():29-41. PubMed ID: 10335669
[TBL] [Abstract][Full Text] [Related]
20. Outcome in schizophrenia: beyond symptom reduction.
Meltzer HY
J Clin Psychiatry; 1999; 60 Suppl 3():3-7; discussion 8. PubMed ID: 10073370
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
